The risks of ischemic and hemorrhagicstroke and poor neurological outcomes after stroke are increased in people with type 2 diabetes. Explore how to manage the hyperacute stroke stage and prevent CV disease.
Everything you need to know from EndoBridge 2023. Find out the latest developments across all aspects of endocrinology and metabolism, and learn about the clinical approaches to common endocrine issues.
STEP-HFpEF trial findings indicate that weekly semaglutide improves heart failure symptoms, physical limitations, and body weight in people with obesity-related heart failure and type 2 diabetes.
The Improving Diabetes Steering Committee outlines the place, value, and advantages of SGLT2 inhibitors in the treatment of type 2 diabetes. With user-friendly tools to support their use.
This UK consensus guideline provides a practical approach to the assessment and management of type 2 diabetes and associated complications in children and young people.
In this Adis podcast, the guideline’s lead authors highlight why offloading treatments are needed, what the updated guideline recommends, and what the offloading future could bring.
Rapidly progressive insulin-dependent diabetes in the absence of islet autoantibodies developed 2 years after starting treatment with the immune checkpoint inhibitor nivolumab.
Early-onset type 2 diabetes (<40 years of age) progresses more rapidly than later-onset disease, insulin is started earlier, and the risk of mortality and complications is increased. How can prevention and treatment be optimized?
Pooled analysis suggests bariatric surgery improves glycemic control, reduces the need for medication, and increases rate of diabetes remission compared with medical or lifestyle management.
HC-HB is a rare movement disorder that can occur in patients with poorly controlled diabetes and hyperglycemia without ketoacidosis. The mainstay of treatment is prompt correction of hyperglycemia.
Cardiovascular outcome trials indicate that incretin-based therapies have renal benefits beyond their glucose-lowering efficacy. But what is the evidence regarding the nephroprotective effects of these anti-diabetes compounds?
UTIs are common in people with diabetes, but how do they compare with UTIs in people without diabetes? And what role might SGLT2 inhibitors have in the increased risk of genitourinary infections?
Maintaining weight loss and high-volume physical activity reduces the risk of CV death in people with type 2 diabetes and overweight/obesity, according to a post-hoc analysis of the Look AHEAD study.
Dyslipidemia is a major risk factor for CVD, especially in people with diabetes. New lipid-lowering treatments are being approved in this population, but what are their effects on glycemic control?
The relationship between diabetes and infection is complex. Find out which infections are most common, what increases the risk and severity of infection, and the principles of treatment.
Diabetic radiculoplexus neuropathy, or Bruns–Garland syndrome, is a rare form of microvascular complication that more commonly affects the lumbosacral plexus and, very rarely, the cervical plexus.
The applications of OCTA in diabetic retinopathy continue to grow. In particular, ultrawide field OCTA and AI based on OCTA images are making advances in terms of diagnostic accuracy.
